New Uscom receives GSA listing to sell to US Government
Uscom receives GSA listing to sell to US Government
- GSA listing required to sell into US Govt and Vet Affairs
- $45B US Federal Govt, Vet Affairs, and State and Local Govt market
- Listing for USCOM 1A soon to be updated with BP+ and SpiroSonic
Uscom announced the receipt of USA General Services Administration Schedule (GSA) listing. The listing provides details of pricing and other terms and conditions of supply and is required to sell into the $45B USD PA Government market that includes the USA Federal Government, Veterans Affairs (VA), and some State and Local Governments. GSA listing is available to businesses, non-profit organisations and educational Institutions to sell products and services to US Government customers, the largest purchaser of medical devices in the USA, which is the largest medical device market in the world.
The benefits of holding a GSA Schedule listing include:
1. Access to $45B USD annual market
2. Reduced pool of competition
3. Shorter simplified sales process
4. Competitive advantages in the Federal market
5. Can be used for all Federal Agencies
6. In some cases can be used for State and Local Government purchasers
The USCOM 1A is currently being loaded onto the GSA Advantage website, the Government shopping site. It has taken over 3 years to receive this listing and required prior FDA approval, the support of current clients, significant pre-existing US sales, product demand of a certain magnitude, and compliance with the application process prior to listing. As the BP+ and SpiroSonic devices receive FDA approval they too will be admitted under the current Uscom GSA listing.
The VA organisation, covered by the GSA listing, is the largest integrated health care system in the USA, providing care at 1,233 health care facilities, including 168 VA Medical Centers and 1,053 outpatient sites (VHA outpatient clinics), serving more than 8.9 million Veterans each year.
Executive Chairman of Uscom, Associate Professor Rob Phillips said “GSA listing is more important than FDA for revenue. FDA is the US regulatory permission to sell, while GSA listing effectively puts our products on the “supermarket shelves” of most US medical device buyers, and this is a real path to volume sales. Now every Government agency purchasing a cardiovascular monitor will have the USCOM 1A offered as a choice with a simplified purchase process. Our new GSA listing should also free up many of our pipeline sales awaiting approval. The application was a consequence of our USCOM 1A sale into the US Naval Base in San Diego, and a general increase in US USCOM 1A demand and enquiries. The GSA Advantage website provides internet marketing of our approved devices, and will be particularly effective for our BP+ and SpiroSonic products once they get FDA clearance.
Uscom have been cautious entering the US market because it’s expensive and is complex to access. The new GSA listing will simplify our US marketing strategy and provides a green light for our sales team in the US, accelerating current sales and greatly expanding new US sales opportunities.”
Reference: